Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Penile Erection

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   43895   clinical trials with a EudraCT protocol, of which   7301   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    43 result(s) found for: Penile Erection. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2007-001058-16 Sponsor Protocol Number: V00147GL202 Start Date*: 2007-04-30
    Sponsor Name:PIERRE FABRE MEDICAMENT
    Full Title: A PHASE II DOUBLE-BLIND VEHICLE-CONTROLLED CROSSOVER SINGLE DOSE (400 µG) V0147 GEL EFFECT AND TOLERANCE STUDY IN SPINAL CORD INJURED PATIENTS WITH ERECTILE DYSFUNCTION
    Medical condition: Erectile dysfunction
    Disease: Version SOC Term Classification Code Term Level
    21.1 10038604 - Reproductive system and breast disorders 10052004 Organic erectile dysfunction PT
    Population Age: Adults Gender: Male
    Trial protocol: FR (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2017-000960-14 Sponsor Protocol Number: FM57 Start Date*: 2018-12-19
    Sponsor Name:Futura Medical Developments Ltd.
    Full Title: A Phase III, dose ranging, multi-centre, randomised, double blind, placebo controlled, home use, parallel group clinical trial of topically-applied glyceryl trinitrate (GTN) for the treatment of er...
    Medical condition: Erectile dysfunction
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10061461 Erectile dysfunction PT
    20.0 10038604 - Reproductive system and breast disorders 10015116 Erectile disturbance LLT
    20.0 10038604 - Reproductive system and breast disorders 10025503 Male erectile disorder LLT
    20.0 10038604 - Reproductive system and breast disorders 10052003 Erectile dysfunction NOS LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: LV (Prematurely Ended) HU (Prematurely Ended) SK (Completed) PL (Prematurely Ended) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2009-009936-56 Sponsor Protocol Number: ACT10775 Start Date*: 2009-05-11
    Sponsor Name:sanofi-aventis recherche et développement
    Full Title: Randomized, double-blind, placebo and active controlled study of the activity of SAR407899A single-dose on the ability to increase duration of penile rigidity, under experimental condition, in pati...
    Medical condition: Mild to moderate erectile dysfunction
    Disease: Version SOC Term Classification Code Term Level
    11.1 10061461 LLT
    Population Age: Adults Gender: Male
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2007-001036-31 Sponsor Protocol Number: A8361011 Start Date*: 2007-06-25
    Sponsor Name:Pfizer Limited, Ramsgate Road, Sandwich, Kent. UK. CT13 9NJ
    Full Title: A 2-COHORT, MULTI-CENTRE, RANDOMIZED, DOUBLE BLIND (3RD PARTY OPEN), PLACEBO CONTROLLED 4-WAY CROSSOVER STUDY TO ASSESS THE EFFICACY OF SINGLE ORAL DOSES OF PF-00446687 ON ERECTILE FUNCTION IN MEN ...
    Medical condition: Male erectile dysfunction (MED).
    Disease: Version SOC Term Classification Code Term Level
    9.1 10052003 Erectile dysfunction NOS LLT
    Population Age: Adults Gender: Male
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-001033-41 Sponsor Protocol Number: H6D-MC-LVFZ Start Date*: 2004-09-22
    Sponsor Name:ELI LILLY
    Full Title: A Randomized, Double-Blind, Parallel-Design, Placebo-Controlled Study to Evluate the Efficacy and Safety of Tadalafil (2.5 mg e 5 mg) administered once daily to men with diabetes mellitus and erect...
    Medical condition: Therapy of erectile disfunction to subjects with diabetes mellitus and erectile disfunction with a 2.5 mg or 5 mg daily dosing.
    Disease: Version SOC Term Classification Code Term Level
    6.1 10061461 PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2004-001549-13 Sponsor Protocol Number: VAR102372 Start Date*: 2004-09-14
    Sponsor Name:GLAXO SMITHKLINE
    Full Title: A pilot, randomized, double-blind, placebo-controlled, crossover study evaluating the efficacy and safety of Vardenafil versus placebo administered 12, 18 and 24 hours prior to initiation of sexual...
    Medical condition: ERECTILE DISFUNCTION
    Disease: Version SOC Term Classification Code Term Level
    6.1 10061461 PT
    Population Age: Adults Gender: Male
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-000536-40 Sponsor Protocol Number: BAY38-9456/12093 Start Date*: 2008-03-29
    Sponsor Name:Bayer HealthCare AG, D-51368 Leverkusen, Germany
    Full Title: Pivotal phase III trial to investigate the efficacy and safety of an Orodispersible Tablet vardenafil versus placebo in the treatment of men with Erectile dysfunction (ED) - a fixed-dose, double-bl...
    Medical condition: Erectile Dysfunction (ED)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10061461 Erectile dysfunction LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: NL (Completed) BE (Completed) DE (Completed) FR (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2014-005571-89 Sponsor Protocol Number: FM53 Start Date*: 2015-06-22
    Sponsor Name:Futura Medical Developments Ltd.
    Full Title: A randomized, double-blind, placebo-controlled, home use, cross-over clinical trial of topically-applied glyceryl trinitrate (GTN) for the treatment of Erectile Dysfunction
    Medical condition: This study investigates a drug intended for the treatment of male patients self-diagnosed with Erectile Dysfunction
    Disease: Version SOC Term Classification Code Term Level
    18.0 10038604 - Reproductive system and breast disorders 10061461 Erectile dysfunction PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2005-004648-30 Sponsor Protocol Number: A7771002 Start Date*: 2006-02-02
    Sponsor Name:Pfizer Limited
    Full Title: A randomized double blind, placebo controlled balanced 4-way crossover study to assess the efficacy of single oral doses of PF-00592379 on erectile function, using 100mg sildenafil as a positive co...
    Medical condition: Male Erectile Dysfunction (MED)
    Disease: Version SOC Term Classification Code Term Level
    8.1 10052003 LLT
    Population Age: Adults Gender: Male
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2018-002597-41 Sponsor Protocol Number: O321 Start Date*: 2018-11-14
    Sponsor Name:Adamed Pharma S.A.
    Full Title: A multi-centre clinical trial evaluating patients’ ability to independently and safely use the medicinal product indicated in the treatment of erectile dysfunction
    Medical condition: Erectile dysfunction
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004872 10052003 Erectile dysfunction NOS LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: PL (Completed)
    Trial results: View results
    EudraCT Number: 2006-004055-38 Sponsor Protocol Number: FM41 Start Date*: 2007-05-21
    Sponsor Name:Futura Medical Developments (FMD) [...]
    1. Futura Medical Developments (FMD)
    2. SSL International Plc
    Full Title: A Phase II Clinical Study to Compare the Efficacy and Safety of Three Doses of Topical Glyceryl Trinitrate (GTN) to Placebo in Subjects with Mild and/or Moderate Erectile Dysfunction (ED)
    Medical condition: Mild and/or moderate erectile dysfunction (ED)
    Disease: Version SOC Term Classification Code Term Level
    8.1 10061461 Erectile dysfunction LLT
    Population Age: Adults Gender: Male
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-005384-66 Sponsor Protocol Number: AUX-CC-807 Start Date*: 2014-04-28
    Sponsor Name:Endo Ventures Limited
    Full Title: A phase 3b, open-label pilot study to evaluate the safety and effectiveness of up to four treatment cycles of AA4500 in combination with the ErecAid® Esteem® Manual Vacuum Therapy System in men wit...
    Medical condition: Peyronie's Disease
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-003290-25 Sponsor Protocol Number: A1481239 Start Date*: 2005-12-23
    Sponsor Name:Pfizer AB
    Full Title: A multicenter, double-blind placebo controlled, fixed dose study with an open-label, flexible dose phase to assess the efficacy of Sildenafil Citrate in providing a better sexual experience includi...
    Medical condition: Erectile Dysfunction
    Disease: Version SOC Term Classification Code Term Level
    8.0 10061461 LLT
    Population Age: Adults Gender: Male
    Trial protocol: SE (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2004-004464-69 Sponsor Protocol Number: VR004/003 Start Date*: 2005-03-22
    Sponsor Name:vectura group plc
    Full Title: A Home Based Phase IIb, Multi-centre, Randomised, Double-Blind, Placebo Controlled, Dose Finding Parallel Group Study to explore the Optimal Dose of Inhaled VR004 in Patients with Erectile Dysfunct...
    Medical condition: erectile dysfunction
    Disease: Version SOC Term Classification Code Term Level
    10052003
    Population Age: Adults Gender: Male
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2018-001418-14 Sponsor Protocol Number: VELOCE Start Date*: 2019-07-11
    Sponsor Name:UMBERTO I - POLICLINICO DI ROMA
    Full Title: Assessment of clinical efficacy of Sildenafil 75 mg orodispersable film vs Sildenafil 100 mg tablet in patients with erectile dysfunction
    Medical condition: Erectile Dysfunction
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10061461 Erectile dysfunction PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-002411-25 Sponsor Protocol Number: A1481237 Start Date*: 2005-08-30
    Sponsor Name:Pfizer Global Pharamceuticals, EuCAn, Pfizer Inc
    Full Title: A prospective multicenter, parallel group study with a single blind phase and a double blind randomised phase, to evaluate the efficacy and satisfaction of Viagra® (Sildenafil Citrate) high dose (1...
    Medical condition: Erectile Dysfunction
    Disease: Version SOC Term Classification Code Term Level
    8.0 10061461 LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Completed) ES (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2007-007670-38 Sponsor Protocol Number: L00074-TD401 Start Date*: 2008-06-23
    Sponsor Name:Pierre Fabre Médicament
    Full Title: "Evaluation of erectyle disfonction in patients suffering from testosterone deficiency, before and after tretament by Testopatch"
    Medical condition: Testosterone deficiency Erectile dysfunction
    Disease: Version SOC Term Classification Code Term Level
    9.1 10061461 Erectile dysfunction LLT
    9.1 10058359 Hypogonadism LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-004239-37 Sponsor Protocol Number: AUX-CC-810 Start Date*: 2015-02-26
    Sponsor Name:Auxilium UK Limited
    Full Title: Long-term safety, curvature deformity characterization, and immunogenicity over time in subjects previously treated with AA4500 for Peyronie’s disease in studies AUX-CC-802, AUX-CC-803, AUX CC 804,...
    Medical condition: Peyronie's Disease
    Disease: Version SOC Term Classification Code Term Level
    17.1 10038604 - Reproductive system and breast disorders 10034766 Peyronies disease LLT
    17.1 10038604 - Reproductive system and breast disorders 10034765 Peyronie's disease PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: SE (Completed) GB (Completed) DK (Completed) ES (Completed) IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-020122-18 Sponsor Protocol Number: BAY 98-7081/14694 Start Date*: 2010-07-23
    Sponsor Name:Bayer HealthCare AG
    Full Title: A prospective, randomized, double-blind, double-dummy, placebo- and active controlled, multicenter study assessing the efficacy and safety of the combination BAY 60 4552 / vardenafil compared to va...
    Medical condition: Erectile dysfunction
    Disease: Version SOC Term Classification Code Term Level
    12.1 10061461 Erectile dysfunction LLT
    Population Age: Adults Gender: Male
    Trial protocol: FR (Completed) DE (Completed) NL (Completed) FI (Completed) ES (Completed) IT (Completed) SE (Completed)
    Trial results: View results
    EudraCT Number: 2004-002172-42 Sponsor Protocol Number: Bay 38-9456/11336 Start Date*: 2005-02-09
    Sponsor Name:Bayer Oy
    Full Title: A randomized, double-blind, double-dummy, multi-center, parallel group study to compare the tolerability and efficacy of once daily vardenafil versus vardenafil PRN versus placebo in men immediatel...
    Medical condition: Erektiohäiriö
    Disease: Version SOC Term Classification Code Term Level
    10061461
    Population Age: Adults Gender: Male
    Trial protocol: FI (Completed) SE (Completed) DE (Completed) AT (Completed) GB (Completed) IT (Completed) ES (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 30 23:32:08 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA